Baidu
map

Pharmacological or TRIB3-Mediated Suppression of ATF4 Transcriptional Activity Promotes Hepatoma Cell Resistance to Proteasome Inhibitor Bortezomib

Ord, T; Ord, D; Kaikkonen, MU; Ord, T

Ord, T (corresponding author), Univ Tartu, Inst Genom, Riia 23b, EE-51010 Tartu, Estonia.

CANCERS, 2021; 13 (10):

Abstract

Simple Summary Proteasome inhibitors are currently used in the treatment of certain blood cancers, and clinical trials to treat solid tumors, includin......

Full Text Link


Baidu
map
Baidu
map
Baidu
map